$BIRK

Birkenstock’s Q3 Reflects Healthy Demand and Closed-toe Shoe Expansion

Birkenstock Holding plc reported Q3 ended June 30 revenue of EUR 719.5M, up 13.3%, while profit fell to EUR 109.6M. Adjusted EBITDA margin was 33.7% vs 33.1% consensus. The company raised FY2026 revenue growth to 15% and adjusted EBITDA to at least EUR 710M, citing stronger direct-to-consumer sales and expanding closed-toe styles.

Original reporting
Published Aug 13, 2026, 2:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 2:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Birkenstock’s Q3 Reflects Healthy Demand and Closed-toe Shoe Expansion — source image
Decision brief

The 30-second read

$BIRKBullishMed
01

Why it matters

The key new information is the Q3 earnings release with revenue growth, margin detail, and a raised fiscal 2026 outlook for both revenue growth and adjusted EBITDA, which can materially change valuation expectations.

02

Market read

A guidance raise tied to strong Q3 demand and channel mix shift is a direct catalyst for repricing Birkenstock’s FY2026 earnings power.

03

What to watch

Traders may focus on whether production capacity investments (capex) translate into sustained sell-through without margin erosion, and whether Q4 revenue lands below Street expectations as one analyst suggests.

Relevance 8/10Novelty 8/10Timing: early trading Thursday after Q3 results and FY2026 outlook raise

Background

Birkenstock Holding plc is a German footwear brand that has been expanding its direct-to-consumer footprint and broadening its product mix into closed-toe styles.

Company-level read

Ticker impact

$BIRKBullishMedium confidence
Context

Birkenstock reported Q3 revenue up 13.3% to 719.5 million euros and raised FY2026 revenue growth to 15% and adjusted EBITDA to at least 710 million euros.

Expected impact

Bullish bias for the next few sessions as traders reprice FY2026 expectations; follow-through depends on Q4 revenue trajectory implied by the raised outlook.

Evidence & confidence

The article contains a fresh earnings print with specific Q3 metrics and explicit FY2026 guidance increases, which typically drives repricing. However, it also notes gross margin pressure from FX and incremental U.S. tariffs, which can cap upside if it persists.

Market effects

Signals continued strength in premium footwear demand and successful channel mix shift toward direct-to-consumer, potentially supportive for discretionary apparel/footwear sentiment.

Growth acceleration across Americas, EMEA, and Asia-Pacific suggests broad-based demand rather than a single-region driver.

Tariff and FX sensitivity highlighted in gross margin could remain a key variable for global consumer brands with international supply chains.

Counterpoint

Despite the guidance raise, profits declined and gross margin fell due to FX and incremental U.S. tariffs, so the quality of earnings could be questioned.

Key entities

  • Birkenstock Holding plc

    Reported Q3 results and raised FY2026 revenue growth to 15% and adjusted EBITDA to at least 710 million euros.

  • Oliver Reichert

    CEO who attributed performance to accelerated direct-to-consumer growth and expanding closed-toe share.

  • Dana Telsey

    Cited view that Birkenstock can win shelf space and standalone stores through lifestyle positioning and proprietary footbed.

  • Simeon Siegel

    Estimated implied Q4 revenue range based on the raised FY2026 guidance.

Related articles

$BIRKMed

EQS-News: Birkenstock Holding plc: BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING AND CONCURRENT SHARE REPURCHASE

Birkenstock Holding plc (BIRKENSTOCK) said it will start an underwritten secondary public offering of $1.0 billion of its ordinary shares sold by an affiliate of L Catterton. Birkenstock will not receive proceeds. After completion, it authorized up to $500 million of share repurchases via redemption at the offering price. J.P. Morgan is the underwriter.

$BIRKMed

Birkenstock Q3 Earnings Call Highlights

Birkenstock (NYSE:BIRK) reported Q3 results and guidance on an earnings call. Management cited 14% constant-currency Americas growth, 15% EMEA growth with 93% full-price realization, and 23% APAC growth. Adjusted gross margin was 59.2% (down 130 bps) due to FX and U.S. tariffs. Adjusted EBITDA rose 11% to €242m; adjusted EPS was €0.74. Full-year adjusted EPS guidance is €1.90 to €2.05.

$BIRKHighAI 9/10

EQS-News: Birkenstock Holding plc: BIRKENSTOCK REPORTS FISCAL THIRD QUARTER 2026 RESULTS WITH 15% CONSTANT F/X REVENUE GROWTH LED BY DTC; RAISES GUIDANCE FOR FY26

Birkenstock Holding plc (NYSE: BIRK) reported fiscal Q3 2026 revenue of EUR 720 million, up 13% reported and 15% constant currency, led by DTC. It raised FY26 guidance to 15% constant-currency revenue growth and Adjusted EBITDA of at least EUR 710 million. The company completed a EUR 230 million accelerated share repurchase and issued EUR 900 million 4.50% senior notes.

$BIRKMedAI 8/10

Why is Birkenstock stock surging today?

Birkenstock shares rose about 7.5% in pre-open trading after the company reported fiscal Q3 2026 results ahead of expectations and raised its full-year outlook. Revenue was €719.5M, up 15% in constant currency versus €713.2M consensus. EPS was €0.74 vs €0.76 consensus. Growth was led by Asia-Pacific (+23%).